SecBot SecBot
SECBOTREPLAY Home › Report › IEX

IEX · IDEX reported Q2 2026 adjusted EPS of $2.32, a 10% beat vs consensus of…

IDEX CORP /DE/ · 8-K filed Jul 29, 2026 at 07:01 ET

At the news

BULLISHIMPACT 7/10

8-K filed Jul 29, 2026 at 07:01 ET

IDEX reported Q2 2026 adjusted EPS of $2.32, a 10% beat vs consensus of $2.11, on record sales of $921M (+6% reported, +5% organic). Full-year organic growth guidance was raised to 5-6% (from 3-4%) and adjusted EPS guidance to $8.70-$8.85 (from $8.35-$8.55), representing ~10% YoY growth at midpoint. Record orders of $1.07B (+29%) underscore exceptional momentum in the Health Science Technologies segment driven by AI/semiconductor and aerospace/defense demand. This marks a second consecutive beat-and-raise quarter.

  • Record quarterly sales of $920.6M, up 6% reported and 5% organic YoY
  • Record adjusted diluted EPS of $2.32, up 12% YoY and 10% above consensus
  • Record orders of $1.07B, up 29% reported and 28% organic YoY
  • HST segment posted 12% organic sales growth and 270bps adjusted EBITDA margin expansion to 28.7%

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access